Effect of Total Knee Arthroplasty on Sarcopenia in Patients With Osteoarthritis in the Knee
Sarcopenia
1 other identifier
observational
58
1 country
1
Brief Summary
Sarcopenia is a wasting disease with the locomotion system in the aged population. It is defined as the decline in muscle mass (lean body mass) and strength with the advance of age. The prevalence of sarcopenia increases with age, reaching an astounding 50% among the population aged over 75 in the United States. Sarcopenia is often associated with frailty, falls, and disability. Studies have found sarcopenia can be a predicting risk factor for fractures in the elderly. In addition, sarcopenia predicted a higher chance of mortality in nursing homes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2018
CompletedFirst Posted
Study publicly available on registry
July 6, 2018
CompletedStudy Start
First participant enrolled
April 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2022
CompletedMarch 22, 2022
March 1, 2022
1.8 years
June 26, 2018
March 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
International Physical Activity Questionnaire (IPAQ)
Questionnaire
one year
DXA scan
Lean Muscle Mass Index
one year
Secondary Outcomes (2)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
one year
Self-Rated 12
one year
Interventions
Effect of Total Knee Arthroplasty on Sarcopenia in Patients with Osteoarthritis in the Knee
Eligibility Criteria
End stage knee osteoarthritis
You may qualify if:
- Male and Female aged over 18 wirh end stage knee OA
- Scheduled for TKA
- Agree to provide written consent
You may not qualify if:
- History of alcoholism or drug abuse
- Pregnancy and breast-feeding
- Presence of serious pathologies
- Steroid-based systemic therapy in progress or interrupted since less than 1 month
- With significant hematologic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong
Hong Kong, Hong Kong
Related Publications (1)
Ho KK, Lau LC, Chau WW, Poon Q, Chung KY, Wong RM. End-stage knee osteoarthritis with and without sarcopenia and the effect of knee arthroplasty - a prospective cohort study. BMC Geriatr. 2021 Jan 4;21(1):2. doi: 10.1186/s12877-020-01929-6.
PMID: 33397330DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professional Consultant
Study Record Dates
First Submitted
June 26, 2018
First Posted
July 6, 2018
Study Start
April 30, 2020
Primary Completion
February 2, 2022
Study Completion
February 2, 2022
Last Updated
March 22, 2022
Record last verified: 2022-03